Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

A faecal microbiota signature with high specificity for pancreatic cancer

Kartal E, Schmidt TSB, Molina-Montes E, Rodríguez-Perales S, Wirbel J, Maistrenko OM, Akanni WA, Alashkar Alhamwe B, Alves RJ, Carrato A, Erasmus HP, Estudillo L, Finkelmeier F, Fullam A, Glazek AM, Gómez-Rubio P, Hercog R, Jung F, Kandels S, Kersting S, Langheinrich M, Márquez M, Molero X, Orakov A, Van Rossum T, Torres-Ruiz R, Telzerow A, Zych K; MAGIC Study investigators; PanGenEU Study investigators; Benes V, Zeller G, Trebicka J, Real FX, Malats N, Bork P.

Gut 2022, 71(7): 1359–1372

DOI: 10.1136/gutjnl-2021-324755

Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients

Garcia ER, Vergara A, Aziz F, Narváez S, Cuesta G, Hernández M, Toapanta D, Marco F, Fernández J, Soriano A, Vila J, Casals-Pascual C.

Clin Microbiol Infect 2022, 28(7): 975–982

DOI: 10.1016/j.cmi.2022.01.004

Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study

Nagata N, Nishijima S, Kojima Y, Hisada Y, Imbe K, Miyoshi-Akiyama T, Suda W, Kimura M, Aoki R, Sekine K, Ohsugi M, Miki K, Osawa T, Ueki K, Oka S, Mizokami M, Kartal E, Schmidt TSB, Molina-Montes E, Estudillo L, Malats N, Trebicka J, Kersting S, Langheinrich M, Bork P, Uemura N, Itoi T, Kawai T.

Gastroenterology 2022, 163(1): 222–238

DOI: 10.1053/j.gastro.2022.03.054

Hepatic encephalopathy

Häussinger D, Dhiman RK, Felipo V, Görg B, Jalan R, Kircheis G, Merli M, Montagnese S, Romero-Gomez M, Schnitzler A, Taylor-Robinson SD, Vilstrup H.

Nat Rev Dis Primers 2022, 8(1): 43

DOI: 10.1038/s41572-022-00366-6

Albumin lipidomics reveals meaningful compositional changes in advanced cirrhosis and its potential to promote inflammation resolution

Casulleras M, Flores-Costa R, Duran-Güell M, Zhang IW, López-Vicario C, Curto A, Fernández J, Arroyo V, Clària J.

Hepatol Commun 2022, 6(6): 1443–1456

DOI: 10.1002/hep4.1893

Liver transplantation in acute-on-chronic liver failure grade 3: Fifty shades of gray

Putignano A, Gustot T.

Liver Transpl 2022, 28(6): 933–935

DOI: 10.1002/lt.26440

Abnormal brain oxygen homeostasis in an animal model of liver disease

Hadjihambi A, Cudalbu C, Pierzchala K, Simicic D, Donnelly C, Konstantinou C, Davies N, Habtesion A, Gourine AV, Jalan R, Hosford PS.

JHEP Rep 2022, 4(8): 100509

DOI: 10.1016/j.jhepr.2022.100509

Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death

Angelova PR, Kerbert AJC, Habtesion A, Hall A, Abramov AY, Jalan R.

JHEP Rep 2022, 4(8): 100510

DOI: 10.1016/j.jhepr.2022.100510

Transplantation in acute-on-chronic liver failure: Feasibility and futility

Queck A, Weiler N, Trebicka J.

Clin Liver Dis 2022, 19(5): 191–193

DOI: 10.1002/cld.1195

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: Another collateral damage of the COVID-19 pandemic?

Görgülü E, Gu W, Trebicka J, Mücke VT, Muecke MM, Friedrich-Rust M, Bojunga J, Zeuzem S, Finkelmeier F, Peiffer KH.

Gut 2022, 71(5): 1036-1038

DOI: 10.1136/gutjnl-2021-325278

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© European Foundation for the Study of Chronic Liver Failure 2024